India’s MedTech manufacturers have made steady progress in recent years, but further development of testing infrastructure ...

GSK plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring initiative aimed at saving £1.9 billion.

Swiss contract drug manufacturer Lonza has set new mid-term targets and reaffirmed its 2026 outlook, announcing a focus on drug manufacturing and major growth strategies during its capital markets day ...

Cipla has issued a voluntary recall of its Fosfomycin Tromethamine Granules for Oral Solution in the US after it failed to ...

Vir Biotechnology has entered a groundbreaking collaboration with Gilead Sciences, valued at up to $1.88 billion, to develop ...

A new drug, ANB033, shows promise in treating gluten-caused intestinal damage in celiac patients, providing significant ...

Biocon has reached an agreement with Roche to launch its biosimilar of the cancer drug Perjeta, with rollouts planned from ...

Sanofi has avoided a potential fine from the EU by promising to cease disparaging the rival flu vaccine Fluad, made by CSL ...